Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$209.80NASDAQ Previous Close - Last Trade as of 4:00PM ET 11/15/19

Today's Change+4.80(2.34%)
Bid (Size)$207.57 (1)
Ask (Size)$215.22 (1)
Day Low / High$205.01 - 210.05
Volume1.6 M

Vertex Gets Positive CHMP Opinion for Expanded Label for Cystic Fibrosis Drug

11:56AM ET 10/18/2019 MT Newswires
Vertex Pharmaceuticals (VRTX) said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of Kalydeco to treat cystic fibrosis patients ages six months to less than 12 months.

The drug has been previously approved in Europe for the treatment of cystic fibrosis patients ages 12 months and older.

The marketing clearance is subject to final approval by the European Commission.

Shares were little changed before midday.

Price: 177.27, Change: -0.45, Percent Change: -0.25